Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

This study has been completed.

Study NCT00064974 Information provided by Celgene Corporation

First Received: July 16, 2003 Last Updated: June 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	February 2006
Primary Completion Date:	January 2007 (Final data collection date for primary outcome measure)